Developing Novel Circulating Epigenetic Biomarkers for Early Detection of Lung Cancer
NCT04814407
·
clinicaltrials.gov ↗
RECRUITING
Status
900
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Interventions
DIAGNOSTIC_TEST:
Blood-derived DNA methylation detection
Sponsor
National Taiwan University Hospital